GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » ROE % Adjusted to Book Value

Samsung BioLogics Co (XKRX:207940) ROE % Adjusted to Book Value : 2.18% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co ROE % Adjusted to Book Value?

Samsung BioLogics Co's ROE % for the quarter that ended in Dec. 2023 was 12.00%. Samsung BioLogics Co's PB Ratio for the quarter that ended in Dec. 2023 was 5.50. Samsung BioLogics Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 2.18%.


Samsung BioLogics Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Samsung BioLogics Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co ROE % Adjusted to Book Value Chart

Samsung BioLogics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.72 0.45 0.69 1.76 1.66

Samsung BioLogics Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.59 1.02 1.41 2.01 2.18

Competitive Comparison of Samsung BioLogics Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Samsung BioLogics Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samsung BioLogics Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Samsung BioLogics Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Samsung BioLogics Co's ROE % Adjusted to Book Value falls into.



Samsung BioLogics Co ROE % Adjusted to Book Value Calculation

Samsung BioLogics Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.12% / 5.50
=1.66%

Samsung BioLogics Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=12.00% / 5.50
=2.18%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Samsung BioLogics Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Samsung BioLogics Co (XKRX:207940) Business Description

Traded in Other Exchanges
N/A
Address
125, Cheomdan-daero, Yeonsu-gu,, Incheon, KOR
Samsung BioLogics Co Ltd engaged in development and manufacturing of bio-healthcare products.The Company works namely in Process Development, cGMP Manufacturing, Aseptic Fill and Finish.

Samsung BioLogics Co (XKRX:207940) Headlines

No Headlines